Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
1.410
-0.015 (-1.05%)
At close: Nov 5, 2026, 4:00 PM EST
1.400
-0.010 (-0.71%)
After-hours: Nov 5, 2026, 4:00 PM EST
Innate Pharma Employees
Innate Pharma had 120 employees as of June 30, 2026. The number of employees decreased by 44 or 26.83% since the number was reported on December 31, 2025.
Employees
120
Change
-44
Growth
-26.83%
Revenue / Employee
$93,378
Profits / Employee
-$451,807
Market Cap
130.26M
Employees Chart
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 120 | -44 | -26.83% |
| Dec 31, 2025 | 164 | -17 | -9.39% |
| Dec 31, 2024 | 181 | 2 | 1.12% |
| Dec 31, 2023 | 179 | -32 | -15.17% |
| Dec 31, 2022 | 211 | -4 | -1.86% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Humacyte | 184 |
| Codexis | 146 |
| Coherus Oncology | 144 |
| Molecular Partners AG | 134 |
| Foghorn Therapeutics | 106 |
| Armata Pharmaceuticals | 61 |
| Compass Therapeutics | 39 |
| NovaBridge Biosciences | 30 |
IPHA News
- 8 hours ago - Innate Pharma Q3 Earnings Call Highlights - MarketBeat
- 10 hours ago - Innate Pharma Earnings Call Transcript: Q3 2026 - Transcripts
- 10 hours ago - Innate Pharma Earnings release: Q3 2026 - Filings
- 10 hours ago - Innate Pharma Earnings release: Q3 2026 - Filings
- 10 hours ago - Innate Pharma Slides: Q3 2026 - Filings
- 17 hours ago - Innate Pharma Reports Third Quarter 2026 Business and Financial Update - Business Wire
- 8 days ago - Innate Pharma Slides: Corporate presentation - Filings
- 9 days ago - Innate Pharma S.A. Announces PACIFIC-9 Phase 3 Trial Readout Timing Updated to H1 2027 - Nasdaq